Investor directory

Angel Medical Systems

Angel Medical Systems, Inc. is a medical device company focused on the development and manufacturing of cardiac monitoring and alerting systems for patients in Brazil. The company's flagship product, the AngelMed Guardian system, is an implantable device that detects and analyzes heart signals, providing alerts for acute episodes of cardiac ischemia associated with coronary artery disease. This system comprises an internal implantable device that vibrates to warn patients of potential cardiac events and tracks critical heart signal data. Additionally, it includes an external telemetry device that transmits information from the implantable device to a programmer, enabling physicians to evaluate heart conditions effectively. The company was incorporated in 2001 and is headquartered in Eatontown, New Jersey.
http://www.angel-med.com
https://app.dealroom.co/companies/angel_medical_systems
https://crunchbase.com/organization/angel-medical-systems
https://linkedin.com/company/angel-medical-systems
https://twitter.com/angelmedsystems
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=38895167

David Fischell Ph.D

CEO

1 past transactions

NeuroPace

Venture Round in 2011
NeuroPace, Inc. is a medical device company based in Mountain View, California, that specializes in developing and manufacturing implantable devices for treating neurological disorders, particularly epilepsy. The company's primary product is the Responsive Neurostimulator (RNS) System, designed for patients with medically refractory partial epilepsy. This system includes a small implantable neurostimulator that monitors brain activity and delivers targeted electrical pulses to specific seizure onset areas. The RNS System comprises both implantable components, such as depth leads and cortical strip leads, and external products, including a programmer that facilitates communication with the implanted device. Founded in 1997, NeuroPace aims to transform the lives of individuals suffering from epilepsy by significantly reducing or eliminating seizures through its innovative technology. The company primarily generates revenue from sales of the RNS System to hospitals and medical facilities that perform the implantation procedures.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.